The effect of chronotherapy with the angiotensin-antagonist in hypertension with sleep apnea syndrome.
Phase 4
- Conditions
- Sleep Apnea Syndrome
- Registration Number
- JPRN-UMIN000007057
- Lead Sponsor
- Tokyo Medical & Dental University, Graduate School of Medical and Dental Sciences, Department of Sleep Modulatory Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient from whom written informed consent is not obtained. 2. Not hypertensive patient. 3. Patient who has the hypersensitivity to irbesartan. 4. Pregnant woman and possible possible pregnant woman.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure
- Secondary Outcome Measures
Name Time Method Heart rate, Urine albumin, CRP, Body weight/Waist circumference, Adiponectin